Despite a robust cash position, Revolution Medicines' high burn rate and lofty valuation increase risk and sensitivity to ...

Cancer Research UK-funded scientists at the University of Cambridge create a test to predict resistance to chemotherapy. The test uses changes to cancer DNA at diagnosis to predict which patients will ...

Detailed price information for Cns Pharmaceuticals Inc (CNSP-Q) from The Globe and Mail including charting and trades.

Researchers have pinpointed the precise pathway in the brain that suppresses pain in times of threatening situations.

Adding docetaxel to androgen deprivation therapy (ADT) plus radiation therapy (RT) failed to improve survival in unfavorable-risk prostate cancer, though the combination may hold benefit for ...

Mechanism of action describes the process by which a molecule, such as a drug, functions to produce a pharmacological effect. A drug’s mechanism of action may refer to its effects on a ...

In comparison to Docetaxel, Nivolumab demonstrated significant improvement in OS (HR: 0.69 [0.63, 0.76], p<0.00001) and PFS (HR: 0.77 [0.70, 0.85], ... larger studies with extended follow-up are ...

Background: Docetaxel (DOC) continues to demonstrate efficacy in metastatic hormone sensitive prostate cancer (mHSPC), particularly in combination with androgen deprivation therapy (ADT) ± androgen ...

Citation: Newly discovered mechanism of mitochondrial dysfunction in obesity may drive insulin resistance and type 2 diabetes (2025, May 30) retrieved 19 June 2025 from https://medicalxpress.com ...

In June 2025, AstraZeneca announced a Phase III study to determine the efficacy and safety of durvalumab + tremelimumab ...